Search

Pulmicort

Pulmicort

budesonide

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Budesonide
Indications/Uses
Bronchial asthma. Respules: Acute laryngotracheobronchitis (croup) in infants & childn. COPD exacerbations in persons w/o signs of acute resp insufficiency.
Click to view Pulmicort detailed prescribing information
Dosage/Direction for Use
Respules Bronchial asthma Adult Initially 1-2 mg bd. Maintenance: 0.5-1 mg bd. Childn Initially 0.5-1 mg bd. Maintenance: 0.25-0.5 mg bd. Acute laryngotracheobronchitis (croup) Infant & childn 2 mg as single dose or 2 1-mg dose separated by 30 min, every 12 hr up to 36 hr or until clinical improvement. COPD exacerbations 4-8 mg daily in 2-4 divided doses. Max: Not >10 days. Turbuhaler Adult 200-800 mcg daily in 2-4 divided doses. Severe cases Up to 1,600 mcg. Childn ≥7 yr 100-800 mcg daily in 2-4 divided doses, 5-7 yr 100-400 mcg daily in 2-4 divided doses.
Click to view Pulmicort detailed prescribing information
Overdosage
View Pulmicort overdosage for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity.
Click to view Pulmicort detailed prescribing information
Special Precautions
Active or quiescent pulmonary TB; fungal or viral resp infections. Pneumonia in patients w/ COPD. Visual disturbances. Hypothalamic-pituitary-adrenal axis suppression, decreased bone mineral density, cataract, glaucoma. Periods of stress, severe asthma attack or elective surgery. Transferring from oral steroids. High-dose & prolonged use. Hepatic impairment. Pregnancy. Growth retardation in childn & adolescents. Respules: Not indicated for rapid relief of bronchospasm. Not suitable as sole therapy for status asthmaticus or other acute asthma exacerbations. Bacterial resp infections. Not to be used w/ +ve pressure delivering systems. Lactation. Turbuhaler: Not intended for rapid relief of acute asthma episodes. Discontinue use if paradoxical bronchospasm occurs. Oral candidiasis. Severe liver cirrhosis. Avoid concomitant use w/ CYP3A4 inhibitors eg, ketoconazole, itraconazole or HIV PIs.
Click to view Pulmicort detailed prescribing information
Adverse Reactions
Oral candidiasis; pneumonia (COPD patients); cough; throat irritation. Respules: Hoarseness, sore throat, tongue & mouth irritation, dry mouth. Turbuhaler: Throat candidiasis.
Click to view Pulmicort detailed prescribing information
Drug Interactions
Increased systemic exposure w/ CYP3A4 inhibitors eg, ketoconazole, itraconazole. Turbuhaler: Increased plasma conc & corticosteroid effects w/ oestrogens, contraceptive steroids. False results w/ ACTH stimulation test.
Click to view Pulmicort detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Pulmicort detailed prescribing information
Storage
View Pulmicort storage conditions for details to ensure optimal shelf-life.
Description
View Pulmicort description for details of the chemical structure and excipients (inactive components).
Action
View Pulmicort mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Antiasthmatic & COPD Preparations
ATC Classification
R03BA02 - budesonide ; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, glucocorticoids.
Patient Counseling Information
View Pulmicort patient counselling information
Presentation/Packing
Form
Pulmicort respules 0.25 mg/mL
Packing/Price
30 × 1's
Form
Pulmicort respules 0.5 mg/mL
Packing/Price
30 × 1's
Form
Pulmicort turbuhaler 100 mcg/dose
Packing/Price
200 dose x 1's
Form
Pulmicort turbuhaler 200 mcg/dose
Packing/Price
100 dose x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in